Michael Becka

Title: Michael Becka: Innovator in Liver Fibrosis Diagnosis

Introduction

Michael Becka is a notable inventor based in Ense, Germany. He has made significant contributions to the field of medical diagnostics, particularly in the assessment of liver fibrosis. His innovative approach utilizes serum marker algorithms to enhance the accuracy of liver disease diagnosis.

Latest Patents

Michael Becka holds a patent for his invention titled "Assessment of liver fibrosis scoring with serum marker algorithms." This patent describes a method for diagnosing liver fibrosis by measuring two or more diagnostic markers. The markers are selected from a specific group, including N-terminal procollagen III propeptide (PIIINP), Collagen IV, Collagen VI, Tenascin, Laminin, Hyaluronan, MMP-2, TIMP-1, and MMP-9/TIMP-1 complex. The mathematical algorithm developed can predict the histological score of a liver biopsy, providing a valuable tool for clinicians.

Career Highlights

Throughout his career, Michael Becka has focused on advancing medical diagnostics. His work has led to the development of innovative methods that improve the understanding and treatment of liver diseases. With a patent count of 1 patent, he continues to contribute to the medical field through his research and inventions.

Collaborations

Michael Becka has collaborated with notable colleagues, including Michael Volker and Werner Kroll. These partnerships have fostered an environment of innovation and have contributed to the success of his projects.

Conclusion

Michael Becka's contributions to liver fibrosis diagnosis exemplify the impact of innovation in the medical field. His patented methods enhance diagnostic accuracy and provide essential tools for healthcare professionals.